Latest filings (excl ownership)
15-15D
Suspension of duty to report
19 Apr 23
EFFECT
Notice of effectiveness
11 Apr 23
EFFECT
Notice of effectiveness
11 Apr 23
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Apr 23
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Apr 23
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Apr 23
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Apr 23
AW
Withdrawal of amendment
5 Apr 23
AW
Withdrawal of amendment
5 Apr 23
AW
Withdrawal of amendment
5 Apr 23
AW
Withdrawal of amendment
5 Apr 23
6-K
Titan Medical Announces Receipt of MCTO
4 Apr 23
POS AM
Prospectus update (post-effective amendment)
3 Apr 23
POS AM
Prospectus update (post-effective amendment)
3 Apr 23
POS AM
Prospectus update (post-effective amendment)
3 Apr 23
POS AM
Prospectus update (post-effective amendment)
3 Apr 23
POS AM
Prospectus update (post-effective amendment)
3 Apr 23
POS AM
Prospectus update (post-effective amendment)
3 Apr 23
25
Voluntary exchange delisting
3 Apr 23
6-K
Titan Medical Provides Corporate Update
3 Apr 23
6-K
Material Change Report
23 Mar 23
6-K
Titan Medical Announces Delays in its Annual Filings and Planned Deregistration with the SEC
22 Mar 23
6-K
Material Change Report
9 Mar 23
6-K
Titan Medical Announces Decision of Nasdaq Hearings Panel to Delist Common Shares
9 Mar 23
6-K
Material Change Report
6 Mar 23
6-K
Material Change Report
6 Mar 23
6-K
Material Change Report
6 Mar 23
6-K
Material Change Report
6 Mar 23
6-K
Material Change Report
6 Mar 23
6-K
Material Change Report
6 Mar 23
6-K
Material Change Report
6 Mar 23
6-K
Material Change Report
6 Mar 23
6-K
Material Change Report
6 Mar 23
6-K
Titan Medical Announces Executive Leadership Updates and Receipt of Nasdaq Notification Regarding Audit Committee Requirements
14 Feb 23
6-K
Titan Medical Provides Corporate Update
8 Feb 23
6-K
Titan Medical Shares Latest Technology Innovation and Announces Meeting Participation During J.P. Morgan Healthcare Conference Week
9 Jan 23
6-K
Titan Medical Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing
28 Dec 22
6-K
Titan Medical Granted Patent Covering User Experience, Further Enhancing its Intellectual Property in Robotic Assisted Surgery
13 Dec 22
6-K
Titan Medical Suspends Special Meeting of Shareholders in Conjunction with Initiation of Strategic Review Process
7 Dec 22
6-K
Titan Medical Implements Cost-Cutting Measures to Support Strategic Review Process
6 Dec 22
Latest ownership filings
SC 13G/A
SABBY MANAGEMENT, LLC
5 Jan 21
SC 13G
ARMISTICE CAPITAL, LLC
18 Jun 20
SC 13G
ARMISTICE CAPITAL, LLC
14 May 20
SC 13G
INTRACOASTAL CAPITAL, LLC
3 Apr 20
SC 13G
SABBY MANAGEMENT, LLC
25 Mar 20
SC 13G/A
Titan Medical Inc
14 Feb 20
SC 13G
Titan Medical Inc
29 Mar 19
SC 13G/A
Titan Medical Inc
14 Feb 19
SC 13G
Titan Medical Inc
20 Aug 18